All articles tagged with #type 1 diabetes
A 26-week randomized trial (INTIMET) in 40 adults with long-standing type 1 diabetes found metformin did not improve insulin resistance or glucose control, but reduced total daily insulin requirements by about 12% compared with placebo, suggesting metformin may ease the insulin burden rather than reverse insulin resistance; researchers are exploring whether gut microbiome interactions explain the effect.
Stanford researchers show that in mice, a combined transplant of donor blood stem cells and mismatched pancreatic islet cells can restore insulin production and retrain the immune system, curing or preventing autoimmune Type 1 diabetes without immunosuppressants or graft-versus-host disease for at least six months, using CD117 antibody–based conditioning to create a hybrid immune system and a path toward human translation (with challenges like donor islet availability).
Scientists have discovered that type 1 diabetes is more severe in young children because their developing pancreas has smaller, more vulnerable beta cell clusters that are more easily destroyed by the immune system. This finding could lead to new treatments, including immunotherapy drugs like teplizumab, which may delay or prevent the disease in children.
A groundbreaking trial at Uppsala University Hospital demonstrated that gene-edited donor islet cells can survive in a human with type 1 diabetes for 12 weeks without immunosuppressive drugs, showing promise for a future cure that avoids lifelong immune suppression.
Mattel has introduced a new Barbie doll with Type 1 diabetes, featuring medical devices like an insulin pump and glucose monitor, as part of its effort to increase representation of medical conditions and disabilities. Developed in partnership with Breakthrough T1D, the doll aims to raise awareness and help children see themselves reflected in their toys. The launch coincided with an advocacy event for diabetes research funding, highlighting the importance of visibility for the condition.
Mattel has released a new Barbie doll that features Type 1 diabetes medical equipment, including an insulin pump and glucose monitor, to promote awareness and inclusivity.
Mattel has launched a Barbie doll with Type 1 diabetes, equipped with a glucose monitor and insulin pump, to promote inclusivity and awareness of the condition among children, in partnership with Breakthrough T1D and reflecting a broader effort to represent diverse health experiences in toys.
Mattel has launched its first Barbie doll with type 1 diabetes, featuring medical devices like a glucose monitor and insulin pump, to promote inclusivity and representation for children with the condition, reflecting ongoing efforts to diversify Barbie dolls in terms of appearance and abilities.
A clinical trial suggests that Ozempic-like drugs, specifically semaglutide, may be effective in treating type 1 diabetes by improving blood sugar control and promoting weight loss, potentially offering a new treatment option alongside insulin. The study involved 72 obese type 1 diabetics, with results showing better blood sugar management and weight loss in those treated with semaglutide, though more research is needed for regulatory approval.
A small trial suggests that GLP-1 drugs like semaglutide may help type 1 diabetes patients maintain healthy glucose levels and lose weight, indicating potential benefits beyond their traditional use in type 2 diabetes.
A new stem cell treatment developed by Vertex Pharmaceuticals shows promise in curing severe type 1 diabetes, with a clinical trial demonstrating significant improvements and reduced insulin dependence in most participants, though further studies are needed to confirm long-term benefits.
A study presented at the American Diabetes Association's meeting shows that an off-the-shelf stem cell therapy called zimislecel enabled 10 out of 12 participants with type 1 diabetes to produce their own insulin and maintain healthy blood glucose levels for at least a year, with no severe hypoglycemia episodes reported after three months.
Hoda Kotb revealed her daughter Hope's diagnosis of Type 1 diabetes on the 'Today' show, sharing how it influenced her decision to leave her 26-year career at NBC and her ongoing efforts to manage her daughter's condition while balancing her family life.
Hoda Kotb revealed her daughter Hope has been diagnosed with Type 1 diabetes, which has impacted her family and her decision to leave the Today show to spend more time with her children. Hope's condition requires constant monitoring, and her health scare in 2023 led to hospital stays and ongoing management. Despite challenges, her family is focused on long-term care and gratitude for medical support.
Hoda Kotb left 'Today' earlier this year to prioritize her family, especially her daughter Hope's health, who has Type 1 diabetes. She returned as a guest in May 2025, sharing her reasons for stepping back and updating on Hope's condition, emphasizing that her daughter's health and happiness are her top priorities. Kotb also dismissed rumors about taking over Kelly Clarkson's show, reaffirming her love for her current role.